# Medical Imaging Phantoms Market > Medical Imaging Phantoms Market Research Report Information By Device Type (X-ray/Fluoroscopy Phantoms, Ultrasound Phantoms, CT Phantoms, MRI Phantoms, Nuclear Imaging Phantoms, and Others), By End User (Hospitals, Academic & Research Institutes, Diagnostic & Reference Laboratories, and Medical Device Companies), And By Region (North America, Europe, Asia-Pacific, And Rest of The World) –Market Forecast Till 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.0% - **2024:** $ 0.22 Billion - **2025:** $ 0.23 Billion - **2035:** $ 0.34 Billion - **Key Players:** Gammex (US), CIRS (US), Modus Medical Devices (CA), Imaging Phantoms (US), QRM (DE), Phantom Laboratory (US), Radiology Support Devices (US), Nuclear Associates (US) **Report ID:** MRFR/MED/20310-HCR · **Pages:** 128 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** May 15, 2026 **URL:** https://www.marketresearchfuture.com/reports/medical-imaging-phantoms-market-21909 --- ## Market Summary ## **Global Medical Imaging Phantoms Market Overview** Medical Imaging Phantoms Market Size was valued at USD 0.21 Billion in 2023. The Medical Imaging Phantoms Market industry is projected to grow from USD 0.22 Billion in 2024 to USD 0.29 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.00% during the forecast period (2024 - 2032). The increasing geriatric population, rising incidence and prevalence of various chronic disorders, rising healthcare sectors, and presence of skilled professionals are expected to be significant market drivers for the Medical Imaging Phantoms Market. Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review ## **Medical Imaging Phantoms Market Trends** **Increasing prevalence of chronic illnesses and the rising geriatric population are driving the market growth** Market CAGR for Medical Imaging Phantoms is driven by the increasing prevalence of chronic illnesses and the rising geriatric population. The growing trend of chronic ailments such as cancer, cardiovascular diseases, neurodegenerative disorders, and chronic respiratory disorders, among others, has become a critical driver that is sustaining the expansion of the market for medical imaging phantoms. Such an environment promotes consistent and accurate diagnostics, treatment, and periodic imaging monitoring. The World Health Organization (WHO), as stated, considers NCDs, being chronic non-communicable diseases, to be the leading cause of death and morbidity  ly. The death rate of chronic illnesses is staggering; 41 million humans from all corners of the globe succumb to chronic health problems each year, which accounts for 71% of all occurrences worldwide. In 2022, there were about 20 million cancer as new cases and 9.7 million deaths from cancer. The current number of people who lived within 5 years of receiving a cancer diagnosis is 53.5 million. There is around a 20% chance an individual will develop cancer during their lifetime. The rates of men and women who die from the disease are about 1 in 9 and 1 in 15, respectively. The aforementioned disorders only trigger the ever-rising demand for imaging devices and phantoms, which play a definitive role in accurate and definitive diagnoses and treatment outcomes. The growing number of geriatric people has a link to the skyrocketing of age-related diseases needing immediate health screening of standard imaging tests. As per the figures of the United Nations Report, 771 million elderly people out of the world's 7.7 billion population have reached the age of 65 years, which is nearly 15% of the world population. These projections state that the emissions rate of this source will grow at an average of 16% by 2050. Besides, it will continue to rise to the level of 24 % by the end of the century. This aging population trend influences the growth of the Medical Imaging Phantoms Market. As a result, it is anticipated that throughout the projection period, demand for the Medical Imaging Phantoms Market will increase due to the increasing prevalence of chronic illnesses and the rising geriatric population. Thus, driving the Medical Imaging Phantoms Market revenue. ## **Medical Imaging Phantoms Market Segment Insights** ### **Medical Imaging Phantoms Market Device Type Insights** The   Medical Imaging Phantoms Market segmentation, based on Device Type, includes X-ray/Fluoroscopy Phantoms, Ultrasound Phantoms, CT Phantoms, MRI Phantoms, Nuclear Imaging Phantoms, and Others. The nuclear imaging phantoms segment dominated the market, accounting for 58% of market revenue. The nuclear imaging phantoms sector is anticipated to expand because the nuclear imaging phantoms are constructed with extremely specific anatomical structures to enhance their applications in biomedical studies as well as bioengineering research. As a result, these anatomically realistic modifications in phantoms will promote the creation of a superior computational model for the nuclear imaging field, which, in return, will drive market growth during the given period. ### **Medical Imaging Phantoms Market End User Insights** The  Medical Imaging Phantoms Market segmentation, based on the End User, includes Hospitals, Academic & Research Institutes, Diagnostic & Reference Laboratories, and Medical Device Companies. The hospitals segment dominated the market, accounting for 58% of market revenue. The majority of hospitals have ongoing activities in research and development concerning medical imaging or diagnostics. They run phantoms through their imaging devices to establish the viability of image interpretation and the development of new methods, like in academic medical centers. One of the hospital practices is to have the same imaging procedures, methods, and equipment used throughout departments to ensure that reliable and efficient outcomes are achieved. Phantoms are designated to create and remain the benchmarks that are applied in healthcare facilities aiming at achieving standardization in imaging. This is done to ensure uniformity in practices. Hence, the need for medical imaging phantoms is cyclical since hospitals continuously do imaging studies every day. Continual demands, for example, from hospitals are guaranteed, and this puts a foundation for a stable environment for phantom suppliers, therefore increasing the market size. **Figure 1:   Medical Imaging Phantoms Market, by End User, 2023 & 2032 (USD Billion)** **** **_Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review_** ### **Medical Imaging Phantoms Market Regional Insights** By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The anticipated expansion of the Medical Imaging Phantoms market in North America can be attributed to several key factors. A rise in healthcare spending and the addition of new CT Scanners and MRI devices in the region brought about the highest growth in the North American market. Health expenditure in the United States increased by 4.1% to $4.4 trillion or $13,493 per capita in the year 2022. Such a growth figure is close to the pre-pandemic one (4.4% in 2019). Health spending amounted to 17.3% of GDP in 2022, which is similar to the 2019 level (17.5%) after an increase in 2020 (19.5%) and 2021 (18.2%). The United States spent as much as $4,464.4 billion on healthcare expenditures in 2022. Among those categories, a yearly average rise was 4.2% for physician services, 4.4% for hospital care and 4.7% for prescription drugs scored from 2012-2022. Also, the disease control and the treatment of various diseases in the US and Canada are likely to influence the adoption of medical imaging devices. Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil. **Figure 2:   MEDICAL IMAGING PHANTOMS MARKET SHARE BY REGION 2023 (USD Billion)** **** **_Source: Secondary Research, Primary Research, MRFR Database and Analyst Review_** Europe Medical Imaging Phantoms Market accounts for the second-largest market share in Western Europe. In many countries, there is a high incidence of chronic illnesses such as cancer, cardiovascular diseases, and nervous disorders. The number of new cases of cancer increased by 2.3%, adding up to 2.74 million in 2022 compared to 2020. Furthermore, the cancer mortality index suffered an advance of 2.4 % in contrast to 2020, as observed by the European Commission. Cancer affects men slightly more than women: 53% share of new cases and 55% of deaths from cancer per both men. The accurate diagnosis and efficient treatment of diseases like these can be achieved by extensive reliance on radiology imaging. This has consequently created a significant need for medical imaging phantoms in the area. Further, the German Medical Imaging Phantoms Market held the largest market share, and the UK Medical Imaging Phantoms Market was the fastest-growing market in the European region The Asia-Pacific Medical Imaging Phantoms Market is expected to grow at the fastest CAGR from 2024 to 2032. The growing number of diseases, such as cancer and cardiovascular diseases, has led to the necessity for speedier and more precise diagnosis and treatment. The WHO in 2020 reported approximately 2.2 million new cancer incidences and 1.4 million deaths from cancer caused in the South-East Asia Region. Nevertheless, these deaths were higher than 10 % of overall deaths, which contributed to high fatality counts in the region. Accordingly, in 2022, there was a conjectured count of 1,461,427 new cases of cancer and a rough incidence rate of 100.4 per 100,000 persons in India. Exactly one Indian among ten people is likely to have a cancer diagnosis during the rest of his life. This helps to respond to the imminent need for medical imaging devices and phantoms, which consequently improve the quality and expand the range of healthcare services. Moreover, China’s Medical Imaging Phantoms Market held the largest market share, and the Indian Medical Imaging Phantoms Market was the fastest-growing market in the Asia-Pacific region. **Medical Imaging Phantoms Key Market Players & Competitive Insights** Leading market players are investing heavily in research and development to expand their product lines, which will help the Medical Imaging Phantoms market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their   footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Medical Imaging Phantoms industry must offer cost-effective items. Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the   Medical Imaging Phantoms industry to benefit clients and increase the market sector. In recent years, the Medical Imaging Phantoms industry has offered some of the most significant advantages to the field of medical diagnostics and treatment optimization. Major players in the Medical Imaging Phantoms Market, including PTW Freiburg GmbH, Gold Standard Phantoms, Kyoto Kagaku Co., Ltd., Pure Imaging Phantoms, Dielectric Corporation, Modus Medical Devices, Carville Limited, Mirion Technologies, Inc., Leeds Test Objects are attempting to increase market demand by investing in research and development operations. Mirion Technologies, Inc. develops, smarts, and supplies the radiation discovery devices, detectors, analyzers, and monitors used by security agencies, the government, and the medical industry. The company provides medical and technological tools. Its medical equipment assortment includes imaging tables and accessories, medical scintigraphy instruments, occupational dosimetry means, and others; its technological line comprises spectroscopy and analysis systems, health physics and radiation protection devices, defense and security, radiation quality control means, reactor instrumentation and more. The company also serves the civil and military industries like nuclear power, laboratories, defense and security, decontamination, decommissioning, and waste management. The business runs its local branches - in Canada, the USA, Europe and Asia. As for Mirion, the headquarters are located in Atlanta, Georgia, the US In September 2020, Mirion Technologies, a provider of commercial solutions to medical nuclear energy, defense, and other cutting-edge technologies, made a strategic acquisition of Biodex Medical Systems, a medical industry leader in supplying medical imaging equipment, rehabilitation systems, and nuclear medicine instruments. The deal will extend the company's footprint in the medical sector. PTW, a dose-measuring company, is a worldwide market position leader specializing in four areas: radiation therapy, diagnostic radiology, metrology, and radiation monitoring. Recently, PTW’s inventions and technologies have been substantively used in general and subspecialty radiation medicine for almost a century. Within this dosimetry market, PTW is, at the core, acting as the primary player. They have emerged as a powerful player in several countries and across several product categories. With the biggest customer network  ly, PTW is recognized as the market leader in the areas of dosimetry technology, which includes more than –50 unique products - detectors, water phantoms, dosemeters, electrometers, and cutting-edge solutions for the quality assurance of clinical radiation equipment. In 2020, PTW acquired a share in phantom manufacturer QRM: Such collaboration combines the deficiency approaches to quality assurance in radiation therapy and diagnostic radiology. **Key companies in the Medical Imaging Phantoms Market include** **Medical Imaging Phantoms Industry Developments** In December 2024, Siemens Healthineers will add a 70-centimeter bore scanner to its 1.5 Tesla Magnetom Flow MRI platform, with the goal of improving patient comfort, sustainability, picture quality, and automated processes. In July 2024, RSD Radiology Support Devices announced the imminent release of Multimodality Phantoms, which would improve accuracy and dependability in medical diagnostics across many imaging modalities, including CT, MRI, and X-ray. In June 2024, Festo bought Carville's process innovations and manufacturing facilities for multilayer plastic manifolds. Production is slated to begin in 2025, expanding our unique solutions in laboratory automation and medical technology. In February 2024, Philips introduced the AI-enabled CT 5300 at #ECR2024, improving diagnostic capabilities and efficiency while also spurring advances in medical imaging phantoms for accurate patient evaluations and difficult cardiac situations. ## **Medical Imaging Phantoms** **Market Segmentation** ### **Medical Imaging Phantoms Market Device Type Outlook** ### **Medical Imaging Phantoms Market End User Outlook** ### **Medical Imaging Phantoms Market** **Regional Outlook** **_ _** **_ _** ## Market Drivers ### Increased Focus on Patient Safety Patient safety remains a top priority in healthcare, and the [Medical Imaging](https://www.marketresearchfuture.com/reports/medical-imaging-market-1995) Phantoms Market is responding to this need. The use of phantoms in imaging procedures helps to minimize radiation exposure and enhance the safety of diagnostic practices. As healthcare providers become more aware of the risks associated with imaging, there is a growing inclination to utilize phantoms for training and quality control. This trend is particularly evident in the fields of radiology and radiation therapy, where the implementation of phantoms is crucial for ensuring safe practices. The market is projected to expand as institutions prioritize patient safety, with an increasing number of facilities investing in advanced phantoms to mitigate risks. This focus on safety is likely to drive innovation within the Medical Imaging Phantoms Market, leading to the development of new products that further enhance patient protection. ### Rising Demand for Quality Assurance Quality assurance in medical imaging is paramount, and the Medical Imaging Phantoms Market plays a crucial role in this aspect. As healthcare facilities strive to meet stringent quality standards, the demand for phantoms that can accurately assess imaging systems is increasing. These phantoms are essential for routine calibration and performance evaluation of imaging equipment, ensuring that diagnostic results are reliable. The market is witnessing a notable increase in the adoption of phantoms for quality assurance, particularly in radiology and nuclear medicine. According to recent estimates, the quality assurance segment is expected to account for a significant share of the Medical Imaging Phantoms Market, reflecting the growing emphasis on patient safety and diagnostic accuracy. This trend is likely to continue as regulatory bodies enforce stricter compliance measures. ### Expansion of Healthcare Infrastructure The expansion of healthcare infrastructure is a significant driver for the Medical Imaging Phantoms Market. As new hospitals and diagnostic centers are established, there is a corresponding need for advanced imaging technologies and quality assurance tools. Medical imaging phantoms are essential for training healthcare professionals and ensuring that imaging equipment operates at optimal levels. The increasing number of healthcare facilities, particularly in emerging markets, is likely to boost the demand for phantoms. Furthermore, government initiatives aimed at improving healthcare access and quality are expected to contribute to market growth. As healthcare systems evolve, the Medical Imaging Phantoms Market is poised to benefit from the rising investments in medical imaging technologies and infrastructure development. ### Growing Research and Development Activities Research and development activities in the field of medical imaging are driving innovation within the Medical Imaging Phantoms Market. As researchers seek to develop new imaging modalities and improve existing technologies, the need for high-quality phantoms becomes increasingly apparent. These phantoms are vital for validating new imaging techniques and ensuring that they meet clinical standards. The market is witnessing a rise in collaborations between academic institutions and industry players, aimed at advancing the capabilities of medical imaging. This collaborative environment is likely to foster the development of novel phantoms that cater to specific research needs. As R&D activities continue to expand, the Medical Imaging Phantoms Market is expected to grow, reflecting the ongoing pursuit of excellence in medical imaging. ### Technological Advancements in Imaging Techniques The Medical Imaging Phantoms Market is experiencing a surge in demand due to rapid technological advancements in imaging techniques. Innovations such as 3D printing and artificial intelligence are enhancing the precision and effectiveness of medical imaging. These advancements allow for the creation of more sophisticated phantoms that can simulate human anatomy with greater accuracy. As a result, healthcare providers are increasingly adopting these advanced phantoms for training and calibration purposes. The market is projected to grow at a compound annual growth rate of approximately 5.2% over the next few years, driven by the need for improved diagnostic accuracy and patient safety. Furthermore, the integration of digital technologies in imaging is likely to further propel the Medical Imaging Phantoms Market, as it enables more efficient workflows and better resource management. ## Future Outlook The Medical Imaging Phantoms Market is projected to grow at a 4.0% CAGR from 2025 to 2035, driven by technological advancements, increasing healthcare investments, and rising demand for diagnostic imaging. **New opportunities:** - Development of customizable phantoms for specific imaging modalities. Expansion into emerging markets with tailored product offerings. Partnerships with healthcare institutions for integrated imaging solutions. By 2035, the market is expected to achieve robust growth, positioning itself as a critical component in medical imaging. ## Segment Insights ### By Device Type: X-ray/Fluoroscopy Phantoms (Largest) vs. MRI Phantoms (Fastest-Growing) In the medical imaging phantoms market, X-ray/Fluoroscopy Phantoms hold the largest medical imaging phantoms market share due to their extensive use in radiology training and quality assurance. This segment has seen consistent demand among educational institutions and hospitals, making it a staple in the market. MRI Phantoms, however, are emerging as the fastest-growing segment, driven by advancements in MRI technology and their increasing use in precision medicine. As healthcare providers adopt more advanced imaging techniques, the demand for MRI Phantoms is expected to surge in the coming years. X-ray/Fluoroscopy Phantoms (Dominant) vs. MRI Phantoms (Emerging) X-ray/Fluoroscopy Phantoms are recognized for their pivotal role in the calibration and testing of imaging systems in radiology. Their robust construction and ability to simulate human anatomy contribute to their popularity among professionals. On the other hand, MRI Phantoms are becoming increasingly significant, catering to the rise of MRI applications in clinical settings. The adaptability of MRI Phantoms to various imaging scenarios positions them as an essential tool in diagnostic accuracy and development. As both segments evolve, their influence on the market reflects the broader trends in medical imaging technology. ### By End User: Hospitals (Largest) vs. Academic & Research Institutes (Fastest-Growing) In the Medical Imaging Phantoms Market, hospitals represent the largest end-user segment, leveraging these phantoms for medical training, quality assurance, and system optimization. Academic and research institutes are rapidly expanding their share, driven by increasing investments in research and development in medical imaging technologies. Diagnostic and reference laboratories, along with medical device companies, also play crucial roles but hold smaller market shares compared to hospitals and academic institutions. Hospitals (Dominant) vs. Academic & Research Institutes (Emerging) Hospitals are the dominant end-users of medical imaging phantoms, utilizing them extensively for simulation, diagnostic accuracy, and patient safety. The reliance on these phantoms in clinical environments enhances their training protocols and compliance with healthcare regulations. In contrast, academic and research institutes represent an emerging segment in this market, with a growing emphasis on innovative research methodologies and partnerships with industry stakeholders. Their investment in state-of-the-art imaging technology and educational training programs positions them as pioneers in developing advanced phantom solutions, fostering a collaborative environment that drives market growth. ## Regional Market Share Analysis ### North America : Leading Innovation and Demand North America is the largest market for medical imaging phantoms, holding approximately 45% of the global market share. The region's growth is driven by advanced healthcare infrastructure, increasing investments in medical imaging technologies, and stringent regulatory standards that ensure quality and safety. The demand for innovative imaging solutions is further fueled by the rising prevalence of chronic diseases and the need for accurate diagnostic tools. The United States is the primary contributor to this market, with key players like Gammex, CIRS, and Imaging Phantoms leading the competitive landscape. Canada also plays a significant role, supported by government initiatives aimed at enhancing healthcare services. The presence of established manufacturers and ongoing research and development activities are pivotal in maintaining North America's market leadership. ### Europe : Emerging Regulatory Frameworks Europe is the second-largest market for medical imaging phantoms, accounting for approximately 30% of the global share. The region's growth is propelled by increasing healthcare expenditures, advancements in imaging technologies, and a strong emphasis on regulatory compliance. The European Union's Medical Device Regulation (MDR) has also catalyzed innovation, ensuring that products meet high safety and efficacy standards, thus boosting market confidence. Germany and the UK are the leading countries in this market, with a robust presence of key players like QRM and Phantom Laboratory. The competitive landscape is characterized by a mix of established companies and emerging startups focusing on innovative solutions. Collaborative efforts between industry and academia are fostering advancements in imaging technologies, further enhancing the market's growth potential. ### Asia-Pacific : Rapid Growth and Adoption Asia-Pacific is witnessing rapid growth in the medical imaging phantoms market, holding approximately 20% of the global share. The region's expansion is driven by increasing healthcare investments, a growing aging population, and rising awareness of advanced diagnostic tools. Countries like China and India are experiencing significant demand due to their expanding healthcare infrastructure and government initiatives aimed at improving medical services. China is the largest market in the region, followed by Japan and India. The competitive landscape is becoming increasingly dynamic, with both local and international players striving to capture market share. Key companies are focusing on product innovation and strategic partnerships to enhance their offerings, thereby contributing to the overall growth of the market in Asia-Pacific. ### Middle East and Africa : Untapped Market Opportunities The Middle East and Africa region is gradually emerging in the medical imaging phantoms market, accounting for approximately 5% of the global share. The growth is primarily driven by increasing healthcare investments, rising awareness of [diagnostic imaging](https://www.marketresearchfuture.com/reports/diagnostic-imaging-market-6765), and government initiatives aimed at improving healthcare infrastructure. Countries like South Africa and the UAE are leading the way, with significant investments in healthcare technology and services. The competitive landscape is still developing, with a mix of local and international players entering the market. Key players are focusing on establishing partnerships and collaborations to enhance their market presence. As healthcare systems in the region continue to evolve, the demand for medical imaging phantoms is expected to grow, presenting new opportunities for market players. ## Competitive Benchmarking The Medical Imaging Phantoms Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and an increasing demand for high-quality imaging solutions. Key players such as Gammex (US), CIRS (US), and Modus Medical Devices (CA) are strategically positioning themselves through innovation and partnerships. Gammex (US) focuses on enhancing its product portfolio with advanced phantoms that cater to diverse imaging modalities, while CIRS (US) emphasizes the development of customizable phantoms to meet specific clinical needs. Modus Medical Devices (CA) is leveraging its expertise in 3D printing technology to create highly accurate phantoms, thereby enhancing its competitive edge in the market. Collectively, these strategies contribute to a robust competitive environment, fostering continuous improvement and innovation within the sector. In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. This approach not only enhances operational efficiency but also allows for better responsiveness to regional market demands. The Medical Imaging Phantoms Market appears to be moderately fragmented, with several players vying for market share. However, the influence of key players is substantial, as they set industry standards and drive technological advancements that smaller companies often follow. In August Gammex (US) announced a partnership with a leading healthcare provider to develop a new line of phantoms specifically designed for pediatric imaging. This collaboration is significant as it addresses a critical gap in the market, where tailored solutions for children are often lacking. By focusing on this niche, Gammex (US) not only enhances its product offerings but also strengthens its market position in a growing segment. In July CIRS (US) launched an innovative phantom that integrates AI technology for real-time imaging quality assessment. This strategic move is indicative of the increasing trend towards digitalization in the medical imaging field. By incorporating AI, CIRS (US) enhances the functionality of its products, providing healthcare professionals with tools that improve diagnostic accuracy and patient outcomes. In September Modus Medical Devices (CA) unveiled a new manufacturing facility dedicated to the production of high-fidelity phantoms using advanced materials. This investment reflects a commitment to sustainability and innovation, as the facility is designed to minimize waste and energy consumption. Such initiatives not only align with global sustainability goals but also position Modus as a forward-thinking leader in the market. As of October the competitive trends in the Medical Imaging Phantoms Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances among key players are shaping the landscape, fostering collaboration that enhances product development and market reach. Looking ahead, it is likely that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, as companies strive to meet the growing demands of the healthcare sector. ## Recent News & Developments In December 2024, Siemens Healthineers will add a 70-centimeter bore scanner to its 1.5 Tesla Magnetom Flow MRI platform, with the goal of improving patient comfort, sustainability, picture quality, and automated processes. In July 2024, RSD Radiology Support Devices announced the imminent release of Multimodality Phantoms, which would improve accuracy and dependability in medical diagnostics across many imaging modalities, including CT, MRI, and X-ray. In June 2024, Festo bought Carville's process innovations and manufacturing facilities for multilayer plastic manifolds. Production is slated to begin in 2025, expanding our unique solutions in laboratory automation and medical technology. In February 2024, Philips introduced the AI-enabled CT 5300 at #ECR2024, improving diagnostic capabilities and efficiency while also spurring advances in medical imaging phantoms for accurate patient evaluations and difficult cardiac situations. ## **Medical Imaging Phantoms Market**  ## Report Scope | MARKET SIZE 2024 | 0.22(USD Billion) | | --- | --- | | MARKET SIZE 2025 | 0.2288(USD Billion) | | MARKET SIZE 2035 | 0.3388(USD Billion) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.0% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Billion | | Key Companies Profiled | Gammex (US), CIRS (US), Modus Medical Devices (CA), Imaging Phantoms (US), QRM (DE), Phantom Laboratory (US), Radiology Support Devices (US), Nuclear Associates (US) | | Segments Covered | Device Type, End User, Region | | Key Market Opportunities | Integration of advanced materials and artificial intelligence in Medical Imaging Phantoms Market enhances diagnostic accuracy. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the Medical Imaging Phantoms Market. | | Countries Covered | North America, Europe, APAC, South America, MEA | ## Frequently Asked Questions **Q: What is the projected market valuation of the Medical Imaging Phantoms Market by 2035?** A: The projected market valuation for the Medical Imaging Phantoms Market by 2035 is 0.3388 USD Billion. **Q: What was the overall market valuation of the Medical Imaging Phantoms Market in 2024?** A: The overall market valuation of the Medical Imaging Phantoms Market in 2024 was 0.22 USD Billion. **Q: What is the expected CAGR for the Medical Imaging Phantoms Market during the forecast period 2025 - 2035?** A: The expected CAGR for the Medical Imaging Phantoms Market during the forecast period 2025 - 2035 is 4.0%. **Q: Which segment had the highest valuation in the Medical Imaging Phantoms Market in 2024?** A: In 2024, the segment with the highest valuation was X-ray/Fluoroscopy Phantoms, valued at 0.05 USD Billion. **Q: What are the key players in the Medical Imaging Phantoms Market?** A: Key players in the Medical Imaging Phantoms Market include Gammex, CIRS, Modus Medical Devices, Imaging Phantoms, QRM, Phantom Laboratory, Radiology Support Devices, and Nuclear Associates. **Q: How much is the Ultrasound Phantoms segment projected to grow by 2035?** A: The Ultrasound Phantoms segment is projected to grow from 0.04 USD Billion in 2024 to 0.06 USD Billion by 2035. **Q: What is the valuation of the MRI Phantoms segment in 2024?** A: The valuation of the MRI Phantoms segment in 2024 was 0.03 USD Billion. **Q: Which end user segment is expected to show the highest growth in the Medical Imaging Phantoms Market?** A: The Hospitals segment is expected to show the highest growth, increasing from 0.088 USD Billion in 2024 to 0.132 USD Billion by 2035. **Q: What is the projected valuation for the Diagnostic & Reference Laboratories segment by 2035?** A: The projected valuation for the Diagnostic & Reference Laboratories segment by 2035 is 0.066 USD Billion. **Q: How does the growth of the Medical Imaging Phantoms Market compare across different device types?** A: The growth across different device types varies, with X-ray/Fluoroscopy Phantoms leading at 0.05 USD Billion in 2024, while Nuclear Imaging Phantoms lagged at 0.025 USD Billion. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/medical-imaging-phantoms-market-21909*